AARS1 and neoplasm: Given the clinical relevance (Figure 5) and the tumor-promoting role (Figure 6) of AARS1, we further analyzed AARS1 mutations in the COSMIC and cBioPortal databases and found that R77Q was the most common AARS1 mutation in patients with GC (Figure 7A).